274 related articles for article (PubMed ID: 32274635)
1. A 10-gene prognostic methylation signature for stage I-III cervical cancer.
Cai S; Yu X; Gu Z; Yang Q; Wen B; Sheng J; Guan R
Arch Gynecol Obstet; 2020 May; 301(5):1275-1287. PubMed ID: 32274635
[TBL] [Abstract][Full Text] [Related]
2. A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
Chen H; Li H; Wang L; Li Y; Yang C
J Obstet Gynaecol; 2022 Feb; 42(2):327-332. PubMed ID: 34082663
[TBL] [Abstract][Full Text] [Related]
3. Construction of Immune-Associated Nomogram for Predicting the Recurrence Survival Risk of Stage I Cervical Cancer.
Wang Y; Zhang L; Wang B; Cheng Y
Biomed Res Int; 2021; 2021():6699131. PubMed ID: 34337046
[TBL] [Abstract][Full Text] [Related]
4. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
6. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
7. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
9. An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
Ma JH; Huang Y; Liu LY; Feng Z
J Int Med Res; 2021 May; 49(5):3000605211018443. PubMed ID: 34034542
[TBL] [Abstract][Full Text] [Related]
10. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
[TBL] [Abstract][Full Text] [Related]
11. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
12. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
Zhang Y; Lu H; Zhang J; Wang S
Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
[TBL] [Abstract][Full Text] [Related]
13. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Wang YL; Zhang YY
Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
[TBL] [Abstract][Full Text] [Related]
14. Definition of a novel vascular invasion-associated multi-gene signature for predicting survival in patients with hepatocellular carcinoma.
Yi B; Tang C; Tao Y; Zhao Z
Oncol Lett; 2020 Jan; 19(1):147-158. PubMed ID: 31897125
[TBL] [Abstract][Full Text] [Related]
15. A cellular senescence-related genes model allows for prognosis and treatment stratification of cervical cancer: a bioinformatics analysis and external verification.
Yang W; An L; Li Y; Qian S
Aging (Albany NY); 2023 Sep; 15(18):9408-9425. PubMed ID: 37768206
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma.
Ma J; Li R; Wang J
Mol Med Rep; 2019 Jul; 20(1):622-632. PubMed ID: 31180552
[TBL] [Abstract][Full Text] [Related]
17. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
[TBL] [Abstract][Full Text] [Related]
18. A risk score system based on DNA methylation levels and a nomogram survival model for lung squamous cell carcinoma.
Zhang M; Sun L; Ru Y; Zhang S; Miao J; Guo P; Lv J; Guo F; Liu B
Int J Mol Med; 2020 Jul; 46(1):252-264. PubMed ID: 32377703
[TBL] [Abstract][Full Text] [Related]
19. Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma.
He Z; Deng T; Duan X; Zeng G
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32789468
[TBL] [Abstract][Full Text] [Related]
20. A prognostic nomogram integrating novel biomarkers identified by machine learning for cervical squamous cell carcinoma.
Li Y; Lu S; Lan M; Peng X; Zhang Z; Lang J
J Transl Med; 2020 Jun; 18(1):223. PubMed ID: 32503630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]